Skip to search formSkip to main contentSkip to account menu

gadoversetamide

Known as: (N,N-Bis(2-((carboxymethyl)(((2-methoxyethyl)carbamoyl)methyl)amino)ethyl)glycinato(3-))gadolinium, Gadoversetamida, gadoversetamide [Chemical/Ingredient] 
A paramagnetic extracellular magnetic resonance imaging (MRI) contrast agent that facilitates visualization of abnormal vascularity. When placed in a… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
While a parenchymal cysticercal lesion in the brain may cause a diagnostic dilemma, radiologic features correlate with pathologic… 
Highly Cited
2010
Highly Cited
2010
PURPOSE To determine the ability of different types of gadolinium-based contrast agents (GBCAs) to stimulate fibroblast… 
2008
2008
To assess the safety data from two large, multicenter, phase 2 trials on the use of gadoversetamide (OptiMARK, Tyco Healthcare… 
2004
2004
PURPOSE To measure serum calcium concentration with three different analytic methods after administration of gadoversetamide and… 
2004
2004
To evaluate the safety of OptiMARK® (gadoversetamide injection) administered via power injector. 
2004
2004
Contrast-enhanced magnetic resonance imaging has become a routine diagnostic imaging procedure. Reports in the literature… 
2001
2001
Wible JH, Galen KP, Wojdyla J. Cardiovascular effects caused by rapid administration of gadoversetamide injection in anesthetized… 
1999
1999
The purpose of this study was to evaluate the safety and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist… 
1999
1999
The purpose of this study was to evaluate the safety and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist…